Friday, May 1, 2026

North Korean Nuclear Missiles Could Hit the United States, Says Assistant Secretary of Defense

North Korea's nuclear threat is growing, prompting the U.S. to invest in advanced defense systems like "Golden Dome for America."

Qualcomm’s New Chip Promises Faster Gaming, Sharper Photos, Smarter AI

Qualcomm's Snapdragon 7 4th Gen boosts CPU by 27%, GPU by 30%, enhances AI, and supports advanced mobile photography and gaming.

Golfing on Duty: Presidential Guard Commander Under Scrutiny

The commanding officer protecting the president and...

Tag: treatment

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

How SK Chemical’s Nose-R Soft Cap Stand Out in Allergy Treatment: A Deep Dive into the OTC Market

SK Chemicals partners with Kyung Nam Pharm to enhance Nose-R Soft Cap sales in pharmacies, boosting allergy treatment distribution.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Male Breast Cancer Has More Than Doubled in 16 Years—So Why Haven’t Survival Rates Improved?

A study shows male breast cancer cases have doubled in 16 years, but survival rates remain low, highlighting treatment disparities.

What You Need to Know About Ganglion Cysts: Symptoms, Causes, and Treatments

Ganglion cysts are benign tumors on joints, often asymptomatic but may require treatment if painful. Regular wrist care is crucial.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

How Ecrac Gel is Revolutionizing Axillary Hyperhidrosis Treatment in Korea: What You Need to Know

Dongwha Pharmaceutical launched Ecrac Gel, Korea's first prescription for underarm hyperhidrosis, promising effective relief for patients.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

How MiniRin and Nokdernah Are Revolutionizing Nocturia Care for Seniors: A Comprehensive Guide

Hanmi Pharmaceutical and Ferring Korea partner to distribute Minirin and Nocdurna for nocturia treatment, enhancing patient access.

How CLOSER AI is Revolutionizing Depression Diagnosis: Insights from KAIST’s Latest Research

KAIST's AI tool CLOSER detects depression symptoms through daily behavior analysis, paving the way for personalized treatment options.

Bio-Revolution: Celltrion’s $700M Biosimilar Is Reshaping the Global Drug Market

Celltrion's breakthrough in antibody biosimilars is transforming healthcare, enhancing access and innovation in treatment options.

Biosimilars No Longer Second-Best: Highlighting Cost Savings and Improved Patient Access

Biosimilars are becoming standard care, with growing confidence in their safety and efficacy, driven by cost savings and improved accessibility.

Saving Poverty vs Free Trade Society? How Celltrion’s Biosimilar Could Reshape the U.S. Healthcare Market

Professor Metz highlights biosimilars' potential to expand patient access to treatments, emphasizing Omliclo's impact at EADV conference.

Man Finds Brain Aneurysm by Accident—Here’s What You Should Know

A man discovers a cerebral aneurysm during a check-up, highlighting the importance of early detection and advancements in treatment options.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.